# NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-K for the period ended Sep 30, 2019

- Company: [NEUROONE MEDICAL TECHNOLOGIES Corp](/companies/nmtc.md) (CIK 1500198)
- Form: 10-K
- Filed: 2019-12-20
- Accepted by EDGAR: Dec 20, 2019, 22:17 ET
- Period: 2019-09-30
- Accession: 0001213900-19-026720
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1500198/000121390019026720/f10k2019_neuroonemedical.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1500198/000121390019026720/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2018-10-01 to 2019-09-30 | $1.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2018-10-01 to 2019-09-30 | −$5.8m | us-gaap:OperatingIncomeLoss |
| Net income | 12 months, 2018-10-01 to 2019-09-30 | −$6.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2018-10-01 to 2019-09-30 | −$0.57 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months, 2018-10-01 to 2019-09-30 | −$5.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2018-10-01 to 2019-09-30 | $58.4k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2019-09-30 | $260.7k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-09-30 | $301.8k | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-30 | $532.6k | us-gaap:Assets |
| Current liabilities | at 2019-09-30 | $1.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-09-30 | $1.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2019-09-30 | −$1.2m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1500198/000121390019026720/f10k2019_neuroonemedical.htm

Filed Dec 20, 2019.
Source: SEC EDGAR, the filing index for accession 0001213900-19-026720. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
